Zdrowie i gospodarka · 04/01/1996
FDA Publishes Guideline on Impurities in New Drug Substances Under ICH
The FDA is releasing a new guideline on impurities in new drug substances, developed in collaboration with the International Conference on Harmonisation, to help applicants meet regulatory requirements for pharmaceutical marketing registration.